Company intelligence / Profile preview

Artu Biologicals Europe

Lelystad, Flevoland, Netherlands

Ownership: Private
Development stage: Other

Overview

Artu Biologicals is a Dutch biotechnology company specializing in the field of allergy immunotherapy (AIT). Based in Lelystad, the company develops and manufactures allergen extracts for both diagnostic purposes and subcutaneous immunotherapy (SCIT) treatments. Since its acquisition by the Danish pharmaceutical company ALK-Abelló in 2007, Artu Biologicals has functioned as a specialized production and research facility within the global ALK network. Its product portfolio primarily addresses respiratory allergies such as allergic rhinitis and allergic asthma. The company is recognized for its expertise in the standardization and production of high-quality allergen preparations.

Therapeutic areas: Immunology
Modalities: Allergen extractBiologic
Industry: Biotech

Beyond the preview

Go deeper on Artu Biologicals Europe.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Artu Biologicals Europe.

Explore the full profile